10-Q quarterly report · filed Nov 6, 2025

Oscar Health, Inc. (OSCR) Q3 2025 10-Q Quarterly Report

Short answer

Oscar Health, Inc. (OSCR) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $9M (up 79.6% year over year) with net income of −$137M.

Q3 2025 key financials · XBRL

Revenue
$9M
+79.6% YoY · +35.5% QoQ
Net income
−$137M
−151.8% YoY · +39.8% QoQ
Operating margin
-1468.6%
EPS (diluted)
−$0.52
−205.9% YoY · +30.7% QoQ

Source: XBRL data from the Oscar Health, Inc. (OSCR) Q3 2025 10-Q on SEC EDGAR. USD.

Oscar Health, Inc. Q3 2025 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue not specified, no YoY comparison provided in the text
  • Net investment income $53.2M for Q3 2025 vs $50.3M Q3 2024, $153.3M for 9M 2025 vs $143.3M 9M 2024
  • Health insurance subsidiaries investment income $50.6M Q3 2025 vs $47.8M Q3 2024
  • Net cash from operating activities $423.0M 9M 2025 vs $631.4M 9M 2024, decrease due to higher claims and expenses
  • Issued $410M convertible senior subordinated notes due 2030 at 2.25% interest; terminated $115M revolving credit facility on September 18, 2025

Risk Factors

  • New risk from CMS Program Integrity Rules enacted June 25, 2025, causing stricter APTC eligibility verification and shortening open enrollment impacting membership
  • Increased estimate of risk adjustment transfer as of Sept 30, 2025 reflects worsening market morbidity, raising potential capital contribution needs and liquidity pressures
  • Regulatory/legal risk from ongoing litigation City of Columbus v. Kennedy, delaying full effect of Program Integrity Rules and creating enrollment uncertainty through 2026
  • Operational risk from potential renewal of enhanced APTCs late in 2025, requiring rapid system and process changes that could disrupt 2026 open enrollment performance
  • Financial risk due to enhanced APTC renewal uncertainty increasing risk of pricing inaccuracies, margin compression, and potential premium rebating under compressed timelines

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Oscar Health, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.